Advertisement
Screener

Tilray Brands, Inc. (TLRY) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

2.3 / 5 stars · 30/64 Roast Me

Tilray Brands, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

Tilray Brands, Inc. (TLRY) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$113.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-25.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets

us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2019-03-25

  • Tilray Brands, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was -$113.00K, a 128.61% decline from fiscal 2017.
  • Tilray Brands, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $395.00K.
Period endValuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month
2018-12-31-$113.00K
10-K · filed 2019-03-25
2017-12-31$395.00K
10-K · filed 2019-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87